nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB2—ulcerative colitis	0.361	0.687	CbGaD
Metoprolol—ABCB1—ulcerative colitis	0.164	0.313	CbGaD
Metoprolol—SLC22A2—Nicotine—ulcerative colitis	0.092	0.278	CbGbCtD
Metoprolol—CYP2C19—Nicotine—ulcerative colitis	0.0303	0.0918	CbGbCtD
Metoprolol—CYP2C19—Cholecalciferol—ulcerative colitis	0.0272	0.0824	CbGbCtD
Metoprolol—ABCB1—Methylprednisolone—ulcerative colitis	0.0251	0.076	CbGbCtD
Metoprolol—CYP2D6—Nicotine—ulcerative colitis	0.0231	0.0698	CbGbCtD
Metoprolol—CYP2D6—Cholecalciferol—ulcerative colitis	0.0207	0.0626	CbGbCtD
Metoprolol—CYP2C19—Prednisone—ulcerative colitis	0.0189	0.0571	CbGbCtD
Metoprolol—ABCB1—Betamethasone—ulcerative colitis	0.0163	0.0494	CbGbCtD
Metoprolol—ABCB1—Prednisolone—ulcerative colitis	0.0161	0.0488	CbGbCtD
Metoprolol—ABCB1—Hydrocortisone—ulcerative colitis	0.0153	0.0462	CbGbCtD
Metoprolol—ABCB1—Prednisone—ulcerative colitis	0.0152	0.0461	CbGbCtD
Metoprolol—CYP2C19—Dexamethasone—ulcerative colitis	0.0118	0.0356	CbGbCtD
Metoprolol—ABCB1—Dexamethasone—ulcerative colitis	0.0095	0.0288	CbGbCtD
Metoprolol—CYP2D6—Dexamethasone—ulcerative colitis	0.00895	0.0271	CbGbCtD
Metoprolol—Metipranolol—ADRB2—ulcerative colitis	0.000596	0.108	CrCbGaD
Metoprolol—Sotalol—ADRB2—ulcerative colitis	0.000531	0.0962	CrCbGaD
Metoprolol—Esmolol—ADRB2—ulcerative colitis	0.000474	0.0857	CrCbGaD
Metoprolol—Bevantolol—ADRB2—ulcerative colitis	0.000468	0.0847	CrCbGaD
Metoprolol—Betaxolol—ADRB2—ulcerative colitis	0.000417	0.0755	CrCbGaD
Metoprolol—Atenolol—ADRB2—ulcerative colitis	0.000413	0.0748	CrCbGaD
Metoprolol—Bisoprolol—ADRB2—ulcerative colitis	0.000403	0.0729	CrCbGaD
Metoprolol—Acebutolol—ADRB2—ulcerative colitis	0.000381	0.069	CrCbGaD
Metoprolol—Oxprenolol—ADRB2—ulcerative colitis	0.000379	0.0685	CrCbGaD
Metoprolol—Alprenolol—ADRB2—ulcerative colitis	0.000346	0.0627	CrCbGaD
Metoprolol—CYP2D6—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000324	0.0178	CbGpPWpGaD
Metoprolol—Pindolol—ADRB2—ulcerative colitis	0.000298	0.0539	CrCbGaD
Metoprolol—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000293	0.0161	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000257	0.0141	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000251	0.0138	CbGpPWpGaD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000239	0.0131	CbGpPWpGaD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000239	0.0131	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—ADRB2—ulcerative colitis	0.000234	0.0129	CbGpPWpGaD
Metoprolol—Chlorphenesin—PTGS2—ulcerative colitis	0.000222	0.0401	CrCbGaD
Metoprolol—ADRB2—GPCRs, Other—CXCR1—ulcerative colitis	0.000207	0.0114	CbGpPWpGaD
Metoprolol—ADRB1—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.000197	0.0108	CbGpPWpGaD
Metoprolol—Atenolol—ABCB1—ulcerative colitis	0.000188	0.0341	CrCbGaD
Metoprolol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000188	0.0103	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000184	0.0101	CbGpPWpGaD
Metoprolol—Acebutolol—ABCB1—ulcerative colitis	0.000174	0.0314	CrCbGaD
Metoprolol—Propranolol—ADRB2—ulcerative colitis	0.000163	0.0294	CrCbGaD
Metoprolol—ADRB2—GPCRs, Other—CXCR2—ulcerative colitis	0.000162	0.00891	CbGpPWpGaD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000149	0.00817	CbGpPWpGaD
Metoprolol—Vertigo—Hydrocortisone—ulcerative colitis	0.000117	0.000975	CcSEcCtD
Metoprolol—Vomiting—Budesonide—ulcerative colitis	0.000117	0.000973	CcSEcCtD
Metoprolol—Syncope—Hydrocortisone—ulcerative colitis	0.000117	0.000973	CcSEcCtD
Metoprolol—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000116	0.00639	CbGpPWpGaD
Metoprolol—Angiopathy—Betamethasone—ulcerative colitis	0.000116	0.000966	CcSEcCtD
Metoprolol—Angiopathy—Dexamethasone—ulcerative colitis	0.000116	0.000966	CcSEcCtD
Metoprolol—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000116	0.00639	CbGpPWpGaD
Metoprolol—Rash—Budesonide—ulcerative colitis	0.000116	0.000965	CcSEcCtD
Metoprolol—Dermatitis—Budesonide—ulcerative colitis	0.000116	0.000964	CcSEcCtD
Metoprolol—Headache—Budesonide—ulcerative colitis	0.000115	0.000959	CcSEcCtD
Metoprolol—Hypertension—Prednisolone—ulcerative colitis	0.000115	0.000959	CcSEcCtD
Metoprolol—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000115	0.000953	CcSEcCtD
Metoprolol—Arrhythmia—Betamethasone—ulcerative colitis	0.000115	0.000951	CcSEcCtD
Metoprolol—Arrhythmia—Dexamethasone—ulcerative colitis	0.000115	0.000951	CcSEcCtD
Metoprolol—Bradycardia—Prednisone—ulcerative colitis	0.000114	0.000944	CcSEcCtD
Metoprolol—Alopecia—Betamethasone—ulcerative colitis	0.000113	0.000941	CcSEcCtD
Metoprolol—Alopecia—Dexamethasone—ulcerative colitis	0.000113	0.000941	CcSEcCtD
Metoprolol—Hypertension—Hydrocortisone—ulcerative colitis	0.000113	0.000937	CcSEcCtD
Metoprolol—Diarrhoea—Azathioprine—ulcerative colitis	0.000113	0.000935	CcSEcCtD
Metoprolol—ADRB1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000112	0.00617	CbGpPWpGaD
Metoprolol—Hallucination—Prednisone—ulcerative colitis	0.000111	0.000923	CcSEcCtD
Metoprolol—Anxiety—Hydrocortisone—ulcerative colitis	0.000111	0.00092	CcSEcCtD
Metoprolol—Vertigo—Triamcinolone—ulcerative colitis	0.000111	0.000918	CcSEcCtD
Metoprolol—Hypersensitivity—Mesalazine—ulcerative colitis	0.00011	0.000917	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00011	0.000917	CcSEcCtD
Metoprolol—Syncope—Triamcinolone—ulcerative colitis	0.00011	0.000916	CcSEcCtD
Metoprolol—Vertigo—Methylprednisolone—ulcerative colitis	0.00011	0.000916	CcSEcCtD
Metoprolol—Syncope—Methylprednisolone—ulcerative colitis	0.00011	0.000914	CcSEcCtD
Metoprolol—Connective tissue disorder—Prednisone—ulcerative colitis	0.00011	0.000911	CcSEcCtD
Metoprolol—Nausea—Budesonide—ulcerative colitis	0.000109	0.000909	CcSEcCtD
Metoprolol—Oedema—Prednisolone—ulcerative colitis	0.000109	0.000906	CcSEcCtD
Metoprolol—Dizziness—Azathioprine—ulcerative colitis	0.000109	0.000904	CcSEcCtD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000109	0.00596	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000109	0.00596	CbGpPWpGaD
Metoprolol—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000108	0.000898	CcSEcCtD
Metoprolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000108	0.00593	CbGpPWpGaD
Metoprolol—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000108	0.000896	CcSEcCtD
Metoprolol—Asthenia—Mesalazine—ulcerative colitis	0.000108	0.000893	CcSEcCtD
Metoprolol—Shock—Prednisolone—ulcerative colitis	0.000107	0.000892	CcSEcCtD
Metoprolol—ADRB1—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000107	0.00589	CbGpPWpGaD
Metoprolol—Oedema—Hydrocortisone—ulcerative colitis	0.000107	0.000885	CcSEcCtD
Metoprolol—Tachycardia—Prednisolone—ulcerative colitis	0.000107	0.000885	CcSEcCtD
Metoprolol—Hypertension—Triamcinolone—ulcerative colitis	0.000106	0.000882	CcSEcCtD
Metoprolol—Pruritus—Mesalazine—ulcerative colitis	0.000106	0.000881	CcSEcCtD
Metoprolol—Hypertension—Methylprednisolone—ulcerative colitis	0.000106	0.00088	CcSEcCtD
Metoprolol—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000106	0.000876	CcSEcCtD
Metoprolol—Shock—Hydrocortisone—ulcerative colitis	0.000105	0.000871	CcSEcCtD
Metoprolol—ADRB2—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000105	0.00576	CbGpPWpGaD
Metoprolol—Vomiting—Azathioprine—ulcerative colitis	0.000105	0.000869	CcSEcCtD
Metoprolol—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000105	0.000868	CcSEcCtD
Metoprolol—Arthralgia—Methylprednisolone—ulcerative colitis	0.000104	0.000868	CcSEcCtD
Metoprolol—Eye disorder—Prednisone—ulcerative colitis	0.000104	0.000866	CcSEcCtD
Metoprolol—ADRB2—Arf6 trafficking events—CDH1—ulcerative colitis	0.000104	0.00573	CbGpPWpGaD
Metoprolol—Anxiety—Methylprednisolone—ulcerative colitis	0.000104	0.000865	CcSEcCtD
Metoprolol—Tachycardia—Hydrocortisone—ulcerative colitis	0.000104	0.000864	CcSEcCtD
Metoprolol—Rash—Azathioprine—ulcerative colitis	0.000104	0.000862	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000104	0.000862	CcSEcCtD
Metoprolol—Dermatitis—Azathioprine—ulcerative colitis	0.000104	0.000861	CcSEcCtD
Metoprolol—Skin disorder—Hydrocortisone—ulcerative colitis	0.000104	0.00086	CcSEcCtD
Metoprolol—Headache—Azathioprine—ulcerative colitis	0.000103	0.000856	CcSEcCtD
Metoprolol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000103	0.000856	CcSEcCtD
Metoprolol—Diarrhoea—Mesalazine—ulcerative colitis	0.000103	0.000852	CcSEcCtD
Metoprolol—Dry mouth—Triamcinolone—ulcerative colitis	0.000102	0.00085	CcSEcCtD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000102	0.0056	CbGpPWpGaD
Metoprolol—Angiopathy—Prednisone—ulcerative colitis	0.000101	0.000841	CcSEcCtD
Metoprolol—Confusional state—Methylprednisolone—ulcerative colitis	0.000101	0.000839	CcSEcCtD
Metoprolol—Immune system disorder—Prednisone—ulcerative colitis	0.000101	0.000837	CcSEcCtD
Metoprolol—Oedema—Triamcinolone—ulcerative colitis	0.0001	0.000834	CcSEcCtD
Metoprolol—Vertigo—Betamethasone—ulcerative colitis	0.0001	0.000833	CcSEcCtD
Metoprolol—Vertigo—Dexamethasone—ulcerative colitis	0.0001	0.000833	CcSEcCtD
Metoprolol—Syncope—Dexamethasone—ulcerative colitis	0.0001	0.000831	CcSEcCtD
Metoprolol—Syncope—Betamethasone—ulcerative colitis	0.0001	0.000831	CcSEcCtD
Metoprolol—Arrhythmia—Prednisone—ulcerative colitis	9.97e-05	0.000828	CcSEcCtD
Metoprolol—Hypotension—Hydrocortisone—ulcerative colitis	9.96e-05	0.000827	CcSEcCtD
Metoprolol—Dizziness—Mesalazine—ulcerative colitis	9.91e-05	0.000823	CcSEcCtD
Metoprolol—Shock—Triamcinolone—ulcerative colitis	9.88e-05	0.00082	CcSEcCtD
Metoprolol—Insomnia—Prednisolone—ulcerative colitis	9.87e-05	0.00082	CcSEcCtD
Metoprolol—Alopecia—Prednisone—ulcerative colitis	9.87e-05	0.000819	CcSEcCtD
Metoprolol—Shock—Methylprednisolone—ulcerative colitis	9.85e-05	0.000818	CcSEcCtD
Metoprolol—Nervous system disorder—Methylprednisolone—ulcerative colitis	9.82e-05	0.000816	CcSEcCtD
Metoprolol—Loss of consciousness—Dexamethasone—ulcerative colitis	9.81e-05	0.000815	CcSEcCtD
Metoprolol—Loss of consciousness—Betamethasone—ulcerative colitis	9.81e-05	0.000815	CcSEcCtD
Metoprolol—Paraesthesia—Prednisolone—ulcerative colitis	9.8e-05	0.000814	CcSEcCtD
Metoprolol—Tachycardia—Triamcinolone—ulcerative colitis	9.8e-05	0.000814	CcSEcCtD
Metoprolol—Mental disorder—Prednisone—ulcerative colitis	9.78e-05	0.000812	CcSEcCtD
Metoprolol—Nausea—Azathioprine—ulcerative colitis	9.78e-05	0.000812	CcSEcCtD
Metoprolol—Tachycardia—Methylprednisolone—ulcerative colitis	9.78e-05	0.000812	CcSEcCtD
Metoprolol—Skin disorder—Methylprednisolone—ulcerative colitis	9.73e-05	0.000808	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	9.71e-05	0.000807	CcSEcCtD
Metoprolol—Hyperhidrosis—Triamcinolone—ulcerative colitis	9.7e-05	0.000806	CcSEcCtD
Metoprolol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	9.68e-05	0.000804	CcSEcCtD
Metoprolol—Insomnia—Hydrocortisone—ulcerative colitis	9.64e-05	0.000801	CcSEcCtD
Metoprolol—Hypertension—Dexamethasone—ulcerative colitis	9.64e-05	0.0008	CcSEcCtD
Metoprolol—Hypertension—Betamethasone—ulcerative colitis	9.64e-05	0.0008	CcSEcCtD
Metoprolol—Paraesthesia—Hydrocortisone—ulcerative colitis	9.57e-05	0.000795	CcSEcCtD
Metoprolol—Vomiting—Mesalazine—ulcerative colitis	9.53e-05	0.000792	CcSEcCtD
Metoprolol—Anxiety—Betamethasone—ulcerative colitis	9.47e-05	0.000786	CcSEcCtD
Metoprolol—Anxiety—Dexamethasone—ulcerative colitis	9.47e-05	0.000786	CcSEcCtD
Metoprolol—Rash—Mesalazine—ulcerative colitis	9.45e-05	0.000785	CcSEcCtD
Metoprolol—Dermatitis—Mesalazine—ulcerative colitis	9.44e-05	0.000784	CcSEcCtD
Metoprolol—Headache—Mesalazine—ulcerative colitis	9.39e-05	0.00078	CcSEcCtD
Metoprolol—Dyspepsia—Hydrocortisone—ulcerative colitis	9.38e-05	0.000779	CcSEcCtD
Metoprolol—Hypotension—Methylprednisolone—ulcerative colitis	9.36e-05	0.000777	CcSEcCtD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	9.36e-05	0.00514	CbGpPWpGaD
Metoprolol—Pain—Prednisolone—ulcerative colitis	9.33e-05	0.000775	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	9.21e-05	0.00506	CbGpPWpGaD
Metoprolol—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	9.2e-05	0.000764	CcSEcCtD
Metoprolol—Fatigue—Hydrocortisone—ulcerative colitis	9.19e-05	0.000763	CcSEcCtD
Metoprolol—Vision blurred—Prednisone—ulcerative colitis	9.16e-05	0.000761	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	9.15e-05	0.000759	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	9.13e-05	0.000758	CcSEcCtD
Metoprolol—Pain—Hydrocortisone—ulcerative colitis	9.12e-05	0.000757	CcSEcCtD
Metoprolol—Oedema—Dexamethasone—ulcerative colitis	9.11e-05	0.000756	CcSEcCtD
Metoprolol—Oedema—Betamethasone—ulcerative colitis	9.11e-05	0.000756	CcSEcCtD
Metoprolol—Insomnia—Triamcinolone—ulcerative colitis	9.08e-05	0.000754	CcSEcCtD
Metoprolol—Insomnia—Methylprednisolone—ulcerative colitis	9.06e-05	0.000752	CcSEcCtD
Metoprolol—Paraesthesia—Triamcinolone—ulcerative colitis	9.01e-05	0.000749	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	9.01e-05	0.00495	CbGpPWpGaD
Metoprolol—Feeling abnormal—Prednisolone—ulcerative colitis	9e-05	0.000747	CcSEcCtD
Metoprolol—Paraesthesia—Methylprednisolone—ulcerative colitis	8.99e-05	0.000747	CcSEcCtD
Metoprolol—Shock—Dexamethasone—ulcerative colitis	8.96e-05	0.000744	CcSEcCtD
Metoprolol—Shock—Betamethasone—ulcerative colitis	8.96e-05	0.000744	CcSEcCtD
Metoprolol—Dyspnoea—Triamcinolone—ulcerative colitis	8.95e-05	0.000743	CcSEcCtD
Metoprolol—Nervous system disorder—Betamethasone—ulcerative colitis	8.93e-05	0.000742	CcSEcCtD
Metoprolol—Nervous system disorder—Dexamethasone—ulcerative colitis	8.93e-05	0.000742	CcSEcCtD
Metoprolol—Thrombocytopenia—Betamethasone—ulcerative colitis	8.92e-05	0.000741	CcSEcCtD
Metoprolol—Thrombocytopenia—Dexamethasone—ulcerative colitis	8.92e-05	0.000741	CcSEcCtD
Metoprolol—Nausea—Mesalazine—ulcerative colitis	8.9e-05	0.00074	CcSEcCtD
Metoprolol—Tachycardia—Dexamethasone—ulcerative colitis	8.89e-05	0.000738	CcSEcCtD
Metoprolol—Tachycardia—Betamethasone—ulcerative colitis	8.89e-05	0.000738	CcSEcCtD
Metoprolol—Dyspepsia—Triamcinolone—ulcerative colitis	8.84e-05	0.000734	CcSEcCtD
Metoprolol—Dyspepsia—Methylprednisolone—ulcerative colitis	8.82e-05	0.000732	CcSEcCtD
Metoprolol—Hyperhidrosis—Betamethasone—ulcerative colitis	8.81e-05	0.000731	CcSEcCtD
Metoprolol—Hyperhidrosis—Dexamethasone—ulcerative colitis	8.81e-05	0.000731	CcSEcCtD
Metoprolol—Feeling abnormal—Hydrocortisone—ulcerative colitis	8.79e-05	0.00073	CcSEcCtD
Metoprolol—Vertigo—Prednisone—ulcerative colitis	8.73e-05	0.000725	CcSEcCtD
Metoprolol—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	8.72e-05	0.000724	CcSEcCtD
Metoprolol—Syncope—Prednisone—ulcerative colitis	8.72e-05	0.000724	CcSEcCtD
Metoprolol—Urticaria—Prednisolone—ulcerative colitis	8.67e-05	0.00072	CcSEcCtD
Metoprolol—Fatigue—Triamcinolone—ulcerative colitis	8.65e-05	0.000719	CcSEcCtD
Metoprolol—Fatigue—Methylprednisolone—ulcerative colitis	8.64e-05	0.000717	CcSEcCtD
Metoprolol—Pain—Triamcinolone—ulcerative colitis	8.58e-05	0.000713	CcSEcCtD
Metoprolol—Loss of consciousness—Prednisone—ulcerative colitis	8.54e-05	0.000709	CcSEcCtD
Metoprolol—Hypotension—Dexamethasone—ulcerative colitis	8.51e-05	0.000707	CcSEcCtD
Metoprolol—Hypotension—Betamethasone—ulcerative colitis	8.51e-05	0.000707	CcSEcCtD
Metoprolol—Urticaria—Hydrocortisone—ulcerative colitis	8.47e-05	0.000703	CcSEcCtD
Metoprolol—Body temperature increased—Hydrocortisone—ulcerative colitis	8.43e-05	0.0007	CcSEcCtD
Metoprolol—Abdominal pain—Hydrocortisone—ulcerative colitis	8.43e-05	0.0007	CcSEcCtD
Metoprolol—Hypertension—Prednisone—ulcerative colitis	8.39e-05	0.000697	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	8.3e-05	0.000689	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	8.3e-05	0.000689	CcSEcCtD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	8.3e-05	0.00456	CbGpPWpGaD
Metoprolol—Arthralgia—Prednisone—ulcerative colitis	8.27e-05	0.000687	CcSEcCtD
Metoprolol—Feeling abnormal—Triamcinolone—ulcerative colitis	8.27e-05	0.000687	CcSEcCtD
Metoprolol—Feeling abnormal—Methylprednisolone—ulcerative colitis	8.25e-05	0.000685	CcSEcCtD
Metoprolol—Anxiety—Prednisone—ulcerative colitis	8.25e-05	0.000685	CcSEcCtD
Metoprolol—Insomnia—Betamethasone—ulcerative colitis	8.24e-05	0.000684	CcSEcCtD
Metoprolol—Insomnia—Dexamethasone—ulcerative colitis	8.24e-05	0.000684	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	8.22e-05	0.000682	CcSEcCtD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	8.2e-05	0.00451	CbGpPWpGaD
Metoprolol—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	8.19e-05	0.00068	CcSEcCtD
Metoprolol—Paraesthesia—Betamethasone—ulcerative colitis	8.18e-05	0.000679	CcSEcCtD
Metoprolol—Paraesthesia—Dexamethasone—ulcerative colitis	8.18e-05	0.000679	CcSEcCtD
Metoprolol—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	8.15e-05	0.00448	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—ADRB2—ulcerative colitis	8.12e-05	0.00446	CbGpPWpGaD
Metoprolol—Hypersensitivity—Prednisolone—ulcerative colitis	8.04e-05	0.000668	CcSEcCtD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	8.03e-05	0.00441	CbGpPWpGaD
Metoprolol—Dyspepsia—Dexamethasone—ulcerative colitis	8.02e-05	0.000666	CcSEcCtD
Metoprolol—Dyspepsia—Betamethasone—ulcerative colitis	8.02e-05	0.000666	CcSEcCtD
Metoprolol—Urticaria—Triamcinolone—ulcerative colitis	7.97e-05	0.000662	CcSEcCtD
Metoprolol—Urticaria—Methylprednisolone—ulcerative colitis	7.96e-05	0.000661	CcSEcCtD
Metoprolol—Body temperature increased—Triamcinolone—ulcerative colitis	7.94e-05	0.000659	CcSEcCtD
Metoprolol—Oedema—Prednisone—ulcerative colitis	7.93e-05	0.000659	CcSEcCtD
Metoprolol—Abdominal pain—Methylprednisolone—ulcerative colitis	7.92e-05	0.000658	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	7.89e-05	0.00433	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	7.87e-05	0.00432	CbGpPWpGaD
Metoprolol—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	7.86e-05	0.000653	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Betamethasone—ulcerative colitis	7.86e-05	0.000653	CcSEcCtD
Metoprolol—Hypersensitivity—Hydrocortisone—ulcerative colitis	7.85e-05	0.000652	CcSEcCtD
Metoprolol—Fatigue—Dexamethasone—ulcerative colitis	7.85e-05	0.000652	CcSEcCtD
Metoprolol—Fatigue—Betamethasone—ulcerative colitis	7.85e-05	0.000652	CcSEcCtD
Metoprolol—Shock—Prednisone—ulcerative colitis	7.8e-05	0.000648	CcSEcCtD
Metoprolol—Pain—Dexamethasone—ulcerative colitis	7.79e-05	0.000647	CcSEcCtD
Metoprolol—Pain—Betamethasone—ulcerative colitis	7.79e-05	0.000647	CcSEcCtD
Metoprolol—Nervous system disorder—Prednisone—ulcerative colitis	7.78e-05	0.000646	CcSEcCtD
Metoprolol—Tachycardia—Prednisone—ulcerative colitis	7.74e-05	0.000643	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	7.72e-05	0.00424	CbGpPWpGaD
Metoprolol—Skin disorder—Prednisone—ulcerative colitis	7.7e-05	0.00064	CcSEcCtD
Metoprolol—Hyperhidrosis—Prednisone—ulcerative colitis	7.67e-05	0.000637	CcSEcCtD
Metoprolol—Asthenia—Hydrocortisone—ulcerative colitis	7.65e-05	0.000635	CcSEcCtD
Metoprolol—Pruritus—Hydrocortisone—ulcerative colitis	7.54e-05	0.000626	CcSEcCtD
Metoprolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.53e-05	0.00413	CbGpPWpGaD
Metoprolol—Feeling abnormal—Betamethasone—ulcerative colitis	7.51e-05	0.000623	CcSEcCtD
Metoprolol—Feeling abnormal—Dexamethasone—ulcerative colitis	7.51e-05	0.000623	CcSEcCtD
Metoprolol—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.49e-05	0.00412	CbGpPWpGaD
Metoprolol—Gastrointestinal pain—Betamethasone—ulcerative colitis	7.45e-05	0.000619	CcSEcCtD
Metoprolol—Gastrointestinal pain—Dexamethasone—ulcerative colitis	7.45e-05	0.000619	CcSEcCtD
Metoprolol—Propranolol—ABCB1—ulcerative colitis	7.41e-05	0.0134	CrCbGaD
Metoprolol—Hypersensitivity—Triamcinolone—ulcerative colitis	7.4e-05	0.000614	CcSEcCtD
Metoprolol—Hypersensitivity—Methylprednisolone—ulcerative colitis	7.38e-05	0.000613	CcSEcCtD
Metoprolol—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	7.32e-05	0.00402	CbGpPWpGaD
Metoprolol—Diarrhoea—Hydrocortisone—ulcerative colitis	7.29e-05	0.000606	CcSEcCtD
Metoprolol—Urticaria—Dexamethasone—ulcerative colitis	7.24e-05	0.000601	CcSEcCtD
Metoprolol—Urticaria—Betamethasone—ulcerative colitis	7.24e-05	0.000601	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Prednisone—ulcerative colitis	7.23e-05	0.0006	CcSEcCtD
Metoprolol—Dizziness—Prednisolone—ulcerative colitis	7.22e-05	0.000599	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	7.21e-05	0.00396	CbGpPWpGaD
Metoprolol—Asthenia—Triamcinolone—ulcerative colitis	7.2e-05	0.000598	CcSEcCtD
Metoprolol—Abdominal pain—Betamethasone—ulcerative colitis	7.2e-05	0.000598	CcSEcCtD
Metoprolol—Body temperature increased—Betamethasone—ulcerative colitis	7.2e-05	0.000598	CcSEcCtD
Metoprolol—Body temperature increased—Dexamethasone—ulcerative colitis	7.2e-05	0.000598	CcSEcCtD
Metoprolol—Abdominal pain—Dexamethasone—ulcerative colitis	7.2e-05	0.000598	CcSEcCtD
Metoprolol—Asthenia—Methylprednisolone—ulcerative colitis	7.19e-05	0.000597	CcSEcCtD
Metoprolol—Insomnia—Prednisone—ulcerative colitis	7.17e-05	0.000596	CcSEcCtD
Metoprolol—Paraesthesia—Prednisone—ulcerative colitis	7.12e-05	0.000591	CcSEcCtD
Metoprolol—Pruritus—Triamcinolone—ulcerative colitis	7.1e-05	0.00059	CcSEcCtD
Metoprolol—Pruritus—Methylprednisolone—ulcerative colitis	7.09e-05	0.000588	CcSEcCtD
Metoprolol—Dizziness—Hydrocortisone—ulcerative colitis	7.05e-05	0.000585	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	7.05e-05	0.00387	CbGpPWpGaD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	7.01e-05	0.00385	CbGpPWpGaD
Metoprolol—Dyspepsia—Prednisone—ulcerative colitis	6.98e-05	0.00058	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	6.93e-05	0.00381	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—ADCY5—ulcerative colitis	6.89e-05	0.00379	CbGpPWpGaD
Metoprolol—Rash—Prednisolone—ulcerative colitis	6.88e-05	0.000572	CcSEcCtD
Metoprolol—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	6.88e-05	0.00378	CbGpPWpGaD
Metoprolol—Dermatitis—Prednisolone—ulcerative colitis	6.88e-05	0.000571	CcSEcCtD
Metoprolol—Diarrhoea—Methylprednisolone—ulcerative colitis	6.85e-05	0.000569	CcSEcCtD
Metoprolol—Fatigue—Prednisone—ulcerative colitis	6.84e-05	0.000568	CcSEcCtD
Metoprolol—Headache—Prednisolone—ulcerative colitis	6.84e-05	0.000568	CcSEcCtD
Metoprolol—Constipation—Prednisone—ulcerative colitis	6.78e-05	0.000563	CcSEcCtD
Metoprolol—Vomiting—Hydrocortisone—ulcerative colitis	6.78e-05	0.000563	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	6.78e-05	0.00372	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	6.77e-05	0.00372	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	6.76e-05	0.00371	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—ADCY5—ulcerative colitis	6.74e-05	0.00371	CbGpPWpGaD
Metoprolol—Rash—Hydrocortisone—ulcerative colitis	6.72e-05	0.000558	CcSEcCtD
Metoprolol—Dermatitis—Hydrocortisone—ulcerative colitis	6.72e-05	0.000558	CcSEcCtD
Metoprolol—Headache—Hydrocortisone—ulcerative colitis	6.68e-05	0.000555	CcSEcCtD
Metoprolol—Dizziness—Triamcinolone—ulcerative colitis	6.64e-05	0.000551	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	6.63e-05	0.00364	CbGpPWpGaD
Metoprolol—Dizziness—Methylprednisolone—ulcerative colitis	6.62e-05	0.00055	CcSEcCtD
Metoprolol—Feeling abnormal—Prednisone—ulcerative colitis	6.54e-05	0.000543	CcSEcCtD
Metoprolol—Asthenia—Dexamethasone—ulcerative colitis	6.53e-05	0.000543	CcSEcCtD
Metoprolol—Asthenia—Betamethasone—ulcerative colitis	6.53e-05	0.000543	CcSEcCtD
Metoprolol—Gastrointestinal pain—Prednisone—ulcerative colitis	6.49e-05	0.000539	CcSEcCtD
Metoprolol—Nausea—Prednisolone—ulcerative colitis	6.48e-05	0.000538	CcSEcCtD
Metoprolol—Pruritus—Betamethasone—ulcerative colitis	6.44e-05	0.000535	CcSEcCtD
Metoprolol—Pruritus—Dexamethasone—ulcerative colitis	6.44e-05	0.000535	CcSEcCtD
Metoprolol—Vomiting—Triamcinolone—ulcerative colitis	6.38e-05	0.00053	CcSEcCtD
Metoprolol—Vomiting—Methylprednisolone—ulcerative colitis	6.37e-05	0.000529	CcSEcCtD
Metoprolol—Nausea—Hydrocortisone—ulcerative colitis	6.33e-05	0.000526	CcSEcCtD
Metoprolol—Rash—Triamcinolone—ulcerative colitis	6.33e-05	0.000526	CcSEcCtD
Metoprolol—Dermatitis—Triamcinolone—ulcerative colitis	6.32e-05	0.000525	CcSEcCtD
Metoprolol—Rash—Methylprednisolone—ulcerative colitis	6.32e-05	0.000524	CcSEcCtD
Metoprolol—Dermatitis—Methylprednisolone—ulcerative colitis	6.31e-05	0.000524	CcSEcCtD
Metoprolol—Urticaria—Prednisone—ulcerative colitis	6.3e-05	0.000523	CcSEcCtD
Metoprolol—Headache—Triamcinolone—ulcerative colitis	6.29e-05	0.000522	CcSEcCtD
Metoprolol—Headache—Methylprednisolone—ulcerative colitis	6.27e-05	0.000521	CcSEcCtD
Metoprolol—Abdominal pain—Prednisone—ulcerative colitis	6.27e-05	0.000521	CcSEcCtD
Metoprolol—Body temperature increased—Prednisone—ulcerative colitis	6.27e-05	0.000521	CcSEcCtD
Metoprolol—Diarrhoea—Dexamethasone—ulcerative colitis	6.23e-05	0.000518	CcSEcCtD
Metoprolol—Diarrhoea—Betamethasone—ulcerative colitis	6.23e-05	0.000518	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	6.17e-05	0.00339	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—CALM3—ulcerative colitis	6.17e-05	0.00339	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	6.06e-05	0.00333	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	6.04e-05	0.00332	CbGpPWpGaD
Metoprolol—Dizziness—Dexamethasone—ulcerative colitis	6.02e-05	0.0005	CcSEcCtD
Metoprolol—Dizziness—Betamethasone—ulcerative colitis	6.02e-05	0.0005	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—CXCR1—ulcerative colitis	6.01e-05	0.0033	CbGpPWpGaD
Metoprolol—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.98e-05	0.00328	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	5.96e-05	0.00328	CbGpPWpGaD
Metoprolol—Nausea—Triamcinolone—ulcerative colitis	5.96e-05	0.000495	CcSEcCtD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	5.95e-05	0.00327	CbGpPWpGaD
Metoprolol—Nausea—Methylprednisolone—ulcerative colitis	5.95e-05	0.000494	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—CXCR1—ulcerative colitis	5.88e-05	0.00323	CbGpPWpGaD
Metoprolol—Hypersensitivity—Prednisone—ulcerative colitis	5.84e-05	0.000485	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	5.83e-05	0.00321	CbGpPWpGaD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	5.82e-05	0.0032	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	5.8e-05	0.00319	CbGpPWpGaD
Metoprolol—Vomiting—Betamethasone—ulcerative colitis	5.79e-05	0.000481	CcSEcCtD
Metoprolol—Vomiting—Dexamethasone—ulcerative colitis	5.79e-05	0.000481	CcSEcCtD
Metoprolol—Rash—Dexamethasone—ulcerative colitis	5.74e-05	0.000477	CcSEcCtD
Metoprolol—Rash—Betamethasone—ulcerative colitis	5.74e-05	0.000477	CcSEcCtD
Metoprolol—Dermatitis—Dexamethasone—ulcerative colitis	5.74e-05	0.000476	CcSEcCtD
Metoprolol—Dermatitis—Betamethasone—ulcerative colitis	5.74e-05	0.000476	CcSEcCtD
Metoprolol—Headache—Dexamethasone—ulcerative colitis	5.71e-05	0.000474	CcSEcCtD
Metoprolol—Headache—Betamethasone—ulcerative colitis	5.71e-05	0.000474	CcSEcCtD
Metoprolol—Asthenia—Prednisone—ulcerative colitis	5.69e-05	0.000473	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	5.68e-05	0.00312	CbGpPWpGaD
Metoprolol—Pruritus—Prednisone—ulcerative colitis	5.61e-05	0.000466	CcSEcCtD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.51e-05	0.00303	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.51e-05	0.00303	CbGpPWpGaD
Metoprolol—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.5e-05	0.00302	CbGpPWpGaD
Metoprolol—Diarrhoea—Prednisone—ulcerative colitis	5.43e-05	0.000451	CcSEcCtD
Metoprolol—Nausea—Dexamethasone—ulcerative colitis	5.41e-05	0.000449	CcSEcCtD
Metoprolol—Nausea—Betamethasone—ulcerative colitis	5.41e-05	0.000449	CcSEcCtD
Metoprolol—ABCB1—Allograft Rejection—IL10—ulcerative colitis	5.35e-05	0.00294	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CCL20—ulcerative colitis	5.27e-05	0.0029	CbGpPWpGaD
Metoprolol—Dizziness—Prednisone—ulcerative colitis	5.25e-05	0.000436	CcSEcCtD
Metoprolol—ADRB2—GPCR ligand binding—CCL20—ulcerative colitis	5.16e-05	0.00283	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	5.11e-05	0.00281	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.11e-05	0.00281	CbGpPWpGaD
Metoprolol—Vomiting—Prednisone—ulcerative colitis	5.04e-05	0.000419	CcSEcCtD
Metoprolol—Rash—Prednisone—ulcerative colitis	5e-05	0.000415	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5e-05	0.00275	CbGpPWpGaD
Metoprolol—Dermatitis—Prednisone—ulcerative colitis	5e-05	0.000415	CcSEcCtD
Metoprolol—Headache—Prednisone—ulcerative colitis	4.97e-05	0.000413	CcSEcCtD
Metoprolol—SLC22A2—Neuronal System—CALM3—ulcerative colitis	4.73e-05	0.0026	CbGpPWpGaD
Metoprolol—Nausea—Prednisone—ulcerative colitis	4.71e-05	0.000391	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—CXCR2—ulcerative colitis	4.7e-05	0.00258	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	4.68e-05	0.00257	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCR2—ulcerative colitis	4.6e-05	0.00253	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	4.58e-05	0.00251	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	4.52e-05	0.00248	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	4.48e-05	0.00246	CbGpPWpGaD
Metoprolol—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.46e-05	0.00245	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CCR6—ulcerative colitis	4.42e-05	0.00243	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	4.36e-05	0.00239	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	4.33e-05	0.00238	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CCR6—ulcerative colitis	4.32e-05	0.00238	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	4.31e-05	0.00237	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	3.98e-05	0.00219	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—PTGER4—ulcerative colitis	3.89e-05	0.00214	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	3.87e-05	0.00213	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—PTGER4—ulcerative colitis	3.81e-05	0.00209	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—GHRL—ulcerative colitis	3.56e-05	0.00196	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—GHRL—ulcerative colitis	3.48e-05	0.00191	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.43e-05	0.00189	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—ADCY5—ulcerative colitis	3.43e-05	0.00188	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCR1—ulcerative colitis	3.39e-05	0.00187	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCR1—ulcerative colitis	3.32e-05	0.00182	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CHP1—ulcerative colitis	3.17e-05	0.00174	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	3.15e-05	0.00173	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCR1—ulcerative colitis	3.08e-05	0.00169	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCR1—ulcerative colitis	3.02e-05	0.00166	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.01e-05	0.00166	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.01e-05	0.00166	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CCL20—ulcerative colitis	2.98e-05	0.00164	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—ADRB2—ulcerative colitis	2.95e-05	0.00162	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	2.93e-05	0.00161	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCL20—ulcerative colitis	2.92e-05	0.0016	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	2.81e-05	0.00154	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—GNA12—ulcerative colitis	2.8e-05	0.00154	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL2—ulcerative colitis	2.8e-05	0.00154	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—GNA12—ulcerative colitis	2.74e-05	0.00151	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—DLD—ulcerative colitis	2.73e-05	0.0015	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCL20—ulcerative colitis	2.71e-05	0.00149	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCR2—ulcerative colitis	2.66e-05	0.00146	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCL20—ulcerative colitis	2.65e-05	0.00145	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCR2—ulcerative colitis	2.6e-05	0.00143	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—GNA12—ulcerative colitis	2.54e-05	0.0014	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CCR6—ulcerative colitis	2.5e-05	0.00137	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—GNA12—ulcerative colitis	2.49e-05	0.00137	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCR6—ulcerative colitis	2.44e-05	0.00134	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	2.43e-05	0.00134	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCR2—ulcerative colitis	2.41e-05	0.00133	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCR2—ulcerative colitis	2.36e-05	0.0013	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCR6—ulcerative colitis	2.27e-05	0.00125	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCR6—ulcerative colitis	2.22e-05	0.00122	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SEL1L—ulcerative colitis	2.21e-05	0.00122	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PTGER4—ulcerative colitis	2.2e-05	0.00121	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.18e-05	0.0012	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SEL1L—ulcerative colitis	2.16e-05	0.00119	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PTGER4—ulcerative colitis	2.15e-05	0.00118	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.04e-05	0.00112	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—GHRL—ulcerative colitis	2.01e-05	0.00111	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PTGER4—ulcerative colitis	2e-05	0.0011	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.98e-05	0.00109	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—GHRL—ulcerative colitis	1.97e-05	0.00108	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PTGER4—ulcerative colitis	1.95e-05	0.00107	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.88e-05	0.00103	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.87e-05	0.00103	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.84e-05	0.00101	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.83e-05	0.00101	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—GHRL—ulcerative colitis	1.83e-05	0.001	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCR1—ulcerative colitis	1.82e-05	0.001	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—GHRL—ulcerative colitis	1.79e-05	0.000983	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCR1—ulcerative colitis	1.78e-05	0.000979	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.77e-05	0.000974	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CALM3—ulcerative colitis	1.77e-05	0.000973	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CALM3—ulcerative colitis	1.73e-05	0.000952	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CHP1—ulcerative colitis	1.73e-05	0.000951	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.67e-05	0.000916	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.66e-05	0.000913	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.63e-05	0.000896	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL20—ulcerative colitis	1.6e-05	0.000878	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL20—ulcerative colitis	1.56e-05	0.000859	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—DLD—ulcerative colitis	1.53e-05	0.000841	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRB2—ulcerative colitis	1.51e-05	0.000831	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GNA12—ulcerative colitis	1.5e-05	0.000826	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—DLD—ulcerative colitis	1.49e-05	0.000821	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.49e-05	0.000818	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GNA12—ulcerative colitis	1.47e-05	0.000808	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCR2—ulcerative colitis	1.43e-05	0.000783	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CXCL8—ulcerative colitis	1.42e-05	0.000782	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.41e-05	0.000777	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DLD—ulcerative colitis	1.41e-05	0.000773	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCR2—ulcerative colitis	1.39e-05	0.000766	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCL8—ulcerative colitis	1.39e-05	0.000765	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—ADCY5—ulcerative colitis	1.38e-05	0.00076	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR6—ulcerative colitis	1.34e-05	0.000736	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS1—ulcerative colitis	1.32e-05	0.000726	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR6—ulcerative colitis	1.31e-05	0.00072	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.29e-05	0.00071	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADCY5—ulcerative colitis	1.28e-05	0.000706	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	1.27e-05	0.000698	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	1.26e-05	0.00069	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	1.24e-05	0.000683	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.24e-05	0.000679	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CALM3—ulcerative colitis	1.19e-05	0.000654	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	1.18e-05	0.000648	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	1.15e-05	0.000634	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	1.08e-05	0.000593	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.08e-05	0.000591	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	1.06e-05	0.00058	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	1.05e-05	0.000575	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	1.03e-05	0.000566	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	1.02e-05	0.000562	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	1.01e-05	0.000554	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.01e-05	0.000553	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1e-05	0.000552	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ABCB1—ulcerative colitis	9.26e-06	0.000509	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	8.94e-06	0.000491	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	8.86e-06	0.000487	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	8.82e-06	0.000485	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ADCY5—ulcerative colitis	8.64e-06	0.000474	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	8.63e-06	0.000474	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.09e-06	0.000445	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	8.05e-06	0.000442	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	8.01e-06	0.00044	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	7.87e-06	0.000433	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	7.83e-06	0.00043	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	7.69e-06	0.000423	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	7.59e-06	0.000417	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	7.52e-06	0.000413	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	7.42e-06	0.000408	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS1—ulcerative colitis	7.4e-06	0.000407	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	7.31e-06	0.000402	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.28e-06	0.0004	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS1—ulcerative colitis	7.22e-06	0.000397	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	7.15e-06	0.000393	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	6.99e-06	0.000384	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	6.83e-06	0.000375	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS1—ulcerative colitis	6.81e-06	0.000374	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.75e-06	0.000371	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CALM3—ulcerative colitis	6.66e-06	0.000366	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CALM3—ulcerative colitis	6.5e-06	0.000357	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—ulcerative colitis	6.44e-06	0.000354	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.37e-06	0.00035	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CALM3—ulcerative colitis	6.13e-06	0.000337	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—ulcerative colitis	5.79e-06	0.000318	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCB1—ulcerative colitis	5.18e-06	0.000285	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—ulcerative colitis	5.07e-06	0.000278	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.83e-06	0.000266	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.77e-06	0.000262	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	4.73e-06	0.00026	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.72e-06	0.000259	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	4.63e-06	0.000254	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RELA—ulcerative colitis	4.58e-06	0.000252	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RELA—ulcerative colitis	4.48e-06	0.000246	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADCY5—ulcerative colitis	4.45e-06	0.000244	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	4.32e-06	0.000237	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	4.22e-06	0.000232	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL2—ulcerative colitis	4.13e-06	0.000227	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	4.11e-06	0.000226	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL2—ulcerative colitis	4.04e-06	0.000222	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	4.02e-06	0.000221	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	3.91e-06	0.000215	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	3.86e-06	0.000212	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	3.82e-06	0.00021	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	3.78e-06	0.000208	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.6e-06	0.000198	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—ulcerative colitis	3.52e-06	0.000193	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	3.47e-06	0.000191	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	3.4e-06	0.000187	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—ulcerative colitis	3.32e-06	0.000182	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—ulcerative colitis	3.24e-06	0.000178	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	3.22e-06	0.000177	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—ulcerative colitis	3.16e-06	0.000174	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	3.15e-06	0.000173	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—ulcerative colitis	2.98e-06	0.000164	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.84e-06	0.000156	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.77e-06	0.000152	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—ulcerative colitis	2.65e-06	0.000146	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.61e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—ulcerative colitis	2.59e-06	0.000142	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—ulcerative colitis	2.43e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—ulcerative colitis	2.37e-06	0.00013	CbGpPWpGaD
